[Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure].

Abstract

The mineralocorticoid receptor antagonists spironolactone and eplerenone have become part of standard medical therapy for heart failure (HF). Randomized clinical trials have shown the clinical efficacy of spironolactone and eplerenone, which lead to lower death rates in patients with systolic HF. Whether these two drugs are equivalent and able to exert a… (More)

Topics

Cite this paper

@article{Tereshchenko2013MineralocorticoidRA, title={[Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure].}, author={S. N. Tereshchenko and I V Zhirov and Iu F Osmolovskaia}, journal={Terapevticheskii arkhiv}, year={2013}, volume={85 12}, pages={137-43} }